Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin dose and duration trial for young children with community-acquired pneumonia
2016-000809-36Phase 3Completed
- Sponsor
- MRC Clinical Trials Unit at UCL
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amoxicillin in community-acquired pneumonia (CAP), pneumonia, sponsored by MRC Clinical Trials Unit at UCL. Started Sep 2016; status: completed.
02
Drugs
amoxicillin
03
Conditions
community-acquired pneumonia (CAP)pneumonia
Beyond the preview
Go deeper on 2016-000809-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000809-36.